Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 14 de 14
Filter
Add more filters










Publication year range
1.
Anim Reprod Sci ; 181: 108-114, 2017 Jun.
Article in English | MEDLINE | ID: mdl-28431864

ABSTRACT

There is a need to develop more integrative sperm quality analysis methods, enabling researchers to evaluate different parameters simultaneously cell by cell. In this work, we present a new multi-parametric fluorescent test able to discriminate different sperm subpopulations based on their labeling pattern and motility characteristics. Cryopreserved semen samples from 20 Holstein bulls were used in the study. Analyses of sperm motility using computer-assisted sperm analysis (CASA-mot), membrane integrity by acridine orange-propidium iodide combination and multi-parametric by the ISAS®3Fun kit, were performed. The new method allows a clear discrimination of sperm subpopulations based on membrane and acrosomal integrity, motility and morphology. It was also possible to observe live spermatozoa showing signs of capacitation such as hyperactivated motility and changes in acrosomal structure. Sperm subpopulation with intact plasma membrane and acrosome showed a higher proportion of motile sperm than those with damaged acrosome or increased fluorescence intensity. Spermatozoa with intact plasmalemma and damaged acrosome were static or exhibit weak movement. Significant correlations among the different sperm quality parameters evaluated were also described. We concluded that the ISAS®3Fun is an integrated method that represents an advance in sperm quality analysis with the potential to improve fertility predictions.


Subject(s)
Cattle/physiology , Semen Analysis/methods , Spermatozoa/physiology , Animals , Fluorescent Dyes , Male , Spermatozoa/cytology , Staining and Labeling
4.
Eur Ann Allergy Clin Immunol ; 36(10): 375-86, 2004 Dec.
Article in English | MEDLINE | ID: mdl-15662966

ABSTRACT

UNLABELLED: Specific immunotherapy (SIT) is frequently used in the treatment of allergic diseases. However, the mechanisms by which SIT achieves clinical improvement remained unclear. We decided to study the in vivo kinetics of this therapy, using a nuclear medicine approach (leukocytes labelled with 99mTc-HMPAO) in patients on maintenance doses of specific immunotherapy with confirmed clinical efficacy. MATERIAL AND METHODS: We studied 13 allergic patients grouped according to different treatment schedules: subcutaneous aqueous allergenic extract (3 latex and 2 hymenoptera venom), subcutaneous depot extract (2 house dust mite and 2 pollens), subcutaneous modified allergens (2 pollens), sublingual extract (2 house dust mites). The control group included two allergic patients submitted to subcutaneous injections of bacterial extract (1 patient--positive control), and aqueous solution (1 patient). At the same time that the therapeutic allergen was administered subcutaneously, the autologous labelled white cells were injected intravenously in a peripheral vein in the contralateral arm. A thoracic dynamic acquisition of 60 mins, 64x64 matrix, 2 frame/min, in anterior view was performed. Static acquisition for 256x256 matrix, during 5 mins each at 60, 90, 120, 180, 240, 300 and 360 mins after the administration of the radiolabelled leukocytes, in thoracic (anterior and posterior), and abdominal view were performed. During the examination, the local erythema was monitored. A similar procedure was undertaken for Sublingual administration of immunotherapy. RESULTS: The inflammatory activity at the site of SIT injection (aqueous depot extract) started in the first hour and the increase was time related. For modified allergen extract and sublingual SIT the activity was present since the beginning of the administration. The ascendant lymphatic drainage, which was directed to the homolateral axillary region, to the lymphoid tissue of the upper mediastinum and to the anterior region of the neck began earlier. Thoracic focalisations were present for all the patients, whereas bowel focalisations were only observed for the subcutaneous route of administration. Sublingual SIT did not induce axillary or intestinal inflammatory focalisations, even though the patients had swallowed the allergenic extract. The uptake coefficient in individualized areas corrected to the uptake coefficient background was also studied. CONCLUSIONS: For the subcutaneous route of administration, except for glutaraldehyde-modified allergen, the local inflammatory activity at the allergenic injection site was significantly higher in depth and was time dependent, maintaining activity even after complete disappearance of the erythema and/or wheal. These results express a prompt inflammatory involvement of the immune system with this allergenic therapy, which was unexpected until now. We also observed differences concerning allergic diseases, the type of allergenic extracts and routes of administration.


Subject(s)
Allergens/therapeutic use , Chemotaxis, Leukocyte , Desensitization, Immunologic , Administration, Sublingual , Adult , Allergens/administration & dosage , Animals , Bee Venoms/administration & dosage , Bee Venoms/pharmacokinetics , Bee Venoms/therapeutic use , Delayed-Action Preparations , Desensitization, Immunologic/methods , Erythema/etiology , Female , Humans , Hypersensitivity, Immediate/diagnostic imaging , Hypersensitivity, Immediate/therapy , Injections, Subcutaneous , Intestines/diagnostic imaging , Intestines/immunology , Kinetics , Latex/administration & dosage , Latex/pharmacokinetics , Latex/therapeutic use , Latex Hypersensitivity/diagnostic imaging , Latex Hypersensitivity/therapy , Leukocyte Transfusion , Lymphoid Tissue/diagnostic imaging , Lymphoid Tissue/immunology , Male , Middle Aged , Pollen/adverse effects , Pyroglyphidae , Radionuclide Imaging , Radiopharmaceuticals , Technetium Tc 99m Exametazime , Tissue Distribution , Wasp Venoms/administration & dosage , Wasp Venoms/pharmacokinetics , Wasp Venoms/therapeutic use
5.
Med Clin (Barc) ; 115(9): 360, 2000 Sep 23.
Article in Spanish | MEDLINE | ID: mdl-11093905
6.
Am J Pediatr Hematol Oncol ; 13(1): 39-41, 1991.
Article in English | MEDLINE | ID: mdl-2029077

ABSTRACT

Fanconi's syndrome with phosphopenic rickets is described in a 2-year-old girl who had been treated for an embryonal sarcoma with multiagent chemotherapy including high-dose ifosfamide. The radiological and biochemical signs of rickets disappeared after treatment with 25-OH vitamin D3 and phosphorus supplements. Monitoring of tubular function in children during and after treatment with ifosfamide is mandatory.


Subject(s)
Fanconi Syndrome/chemically induced , Growth Disorders/chemically induced , Ifosfamide/adverse effects , Rickets/chemically induced , Child, Preschool , Fanconi Syndrome/complications , Fanconi Syndrome/urine , Female , Growth Disorders/etiology , Humans , Rickets/complications
SELECTION OF CITATIONS
SEARCH DETAIL
...